-
Living With GIST: 10 Years of Molecularly Targeted Therapy
On April 9, 2010 GIST patients and familiy members flocked to Dana-Farber for a day-long event organized by George Demetri, MD and Suzanne George, MD to celebrate the 10-year anniversary of the first drug for treatment of GIST, imatinib (Gleevec). You can see the agenda HERE Below are some photos from this memorable event! A […]
Continue reading -
ESMO GIST Guidelines
The European Society of Medical Oncology (ESMO) has updated its GIST practice guidelines. You can access the new document for free. Click on the title below. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-upP.G. Casali and J.-Y. Blay on behalf of the ESMO/CONTICANET/EUUROBONET Consensus Panel of ExpertsAnnals of Oncology 21 (supplement […]
Continue reading -
ASCO 2010 News on GIST
Becky and Carolyn Report from ASCO! The intrepid pair Carolyn Grobe and Becky Bensenhaver went to Chicago for the 2010 ASCO meeting June 4-8, serving as news scouts for GIST patients to report new developments in GIST research and treatment. Becky received an ASCO scholarship to attend as a patient advocate on behalf of GIST […]
Continue reading -
NCCN GIST Task Force Update
The NCCN GIST Task Force has published a revision to its recommendations entitled: NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors. You may download the pdf of this document at this link: http://www.jnccn.org/content/8/Suppl_2/S-1.full.pdf+html
Continue reading -
GIST at 2009 ASCO
The American Society for Clinical Oncology (ASCO) 2009 meeting was held in Orlando May 29- June 2. Link here for a list of most of the GIST abstracts presented at the meeting. Webcasts of selected presentations are free-access on the ASCO website as of December 2009.
Continue reading -
24 Years on Gleevec!
ST. LOUIS On Saturday May 16 a GIST Gathering was held at the Barnes Jewish Hospital complex of the Washington University School of medicine in St. Louis. It was the third such meeting in St. Louis and has GIST patients from neighboring states also attending. At the meeting three long-time Gleevec users met and shared […]
Continue reading -
Adjuvant Imatinib in Europe
The European Commission has appproved adjuvant imatinib in GIST patients with significant risk of recurrence. In March the European Medicines Agency had recommended approval for use of imatinib (Glivec or Gleevec) for adjuvant use (prescription to prevent recurrence after successful surgical resection of primary GIST) for patients with an intermediate or high risk of recurrence. […]
Continue reading -
Sarcoma Bike Tour 2006 Funds Awarded
Sarcoma Bike Tour Funds Awarded In July 2006 , Team GIST Support participated in the Team Sarcoma Bike Tour organized by the Liddy Shriver Sarcoma Initiative. Team GIST Support, pictured below, included Megan Lamb, Rob Lamb, and Jonathan Craig. The goal for Team GIST Support was to raise funds for two young researchers: Dr. Anette […]
Continue reading -
Barbara and Sherri Visit Novartis
Novartis had their "kick off"event on January 30, 2009 to recognize the achievement of the oncology department and to lay the foundation for future success in the new year. Their goal this coming year is "Winning for the Patient". One of their big FDA approvals was for adjuvant Gleevec. The half day meeting was for […]
Continue reading -
IGF signals in GIST
Insulin-related growth factor family: potential role in GIST Several 2008 papers suggest that the insulin-related growth factors and associated receptors may be treatment targets for GISTs, including wild-type adult GISTs as well as pediatric GISTs and Carney Triad. This is exciting because development of drugs relevant to the insulin-related growth factor (IGF) family is already […]
Continue reading